TB researchers will test a new Bayer antibiotic
Article Abstract:
Tuberculosis, one of the most fatal illnesses in poverty stricken areas of the world is being given a new cure. Tuberculosis researchers partnering with Bayer AG are conducting clinical trials of a new antibiotic that could half treatment time.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Small firms seek to profit from drug giants' castoffs
Article Abstract:
Led by biochemists like Speedel Holding AG's Alice Huxley, s mall pharmaceutical companies are developing drugs that larger companies like Novartis AG had decided weren't financially viable.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Cancer drug Gleevec is shown to carry heart risk
Article Abstract:
The leukemia fighting drug, Gleevec, has been shown in a significant study to in some cases cause heart failure. The finding may be a stumbling block to the blockbuster cancer drug.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Classic beamer's special winch control. Star is first cat of her kind. New aids in design software
- Abstracts: Breast-cancer drug wins FDA approval. Merck cervical-cancer vaccine cleared for use in girls, women. Glaxo seeks approval for drug
- Abstracts: Aeroports de Paris listing to raise up to $1.79 billion. EADS nears end to turmoil. Airports operator spreads its wings
- Abstracts: Philips net rises on asset sales; chip results sag. Philips net rises, though dollar weighs on sales. Philips earnings rise sharply, lifted by sale of chip-firm stake